Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Remember this

<< Previous

Bullboard Posts

Next >>

Post by bealerton Jul 25, 2022 2:59pm

202 Views

Post# 34849001

RE:RE:RE:Remember this

Somebody still thinks the science is OK. 4 people are bidding for 257,000 shares at 19 cents.

Does anyone have any form of decent contact with the Sirona wizzards? I can't get anything out of them and maybe someone can shame them into a logical reply.

Any takers, anybody have any advice?

BeAlert

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China